What the six lenses say about CONCORDBIO — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How CONCORDBIO’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +2.3pp | +1.1pp | +8.5pp | +17.8pp | +22.3pp | -6.4pp |
Nifty 500 Broad-market baseline | +2.3pp | +1.1pp | +7.4pp | +16.2pp | +16.5pp | -11.6pp |
Sector Own-sector index | — | — | +4.6pp | +10.1pp | +3.4pp | -32.4pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
CONCORDBIO daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
CONCORDBIO ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 216 | 310 | 244 | 430 | 204 | 247 | 278 | 326 |
| ↳ change QoQ | — | +43.7% | -21.3% | +76.1% | -52.6% | +21.1% | +12.6% | +17.3% |
| EBITDA (₹cr) | 92 | 147 | 113 | 189 | 61 | 88 | 98 | 118 |
| EBITDA margin | 42.4% | 47.3% | 46.1% | 44.0% | 29.9% | 35.6% | 35.3% | 36.2% |
| PAT (₹cr) | 60 | 96 | 76 | 140 | 44 | 63 | 64 | 88 |
| ↳ change QoQ | — | +60.7% | -20.7% | +84.4% | -68.6% | +43.2% | +1.6% | +37.5% |
| Net margin | 27.6% | 30.9% | 31.1% | 32.6% | 21.6% | 25.5% | 23.0% | 27.0% |
| EPS (₹) | 5.70 | 9.15 | 7.26 | 13.42 | 4.21 | 6.08 | 6.16 | 8.49 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding CONCORDBIO (9)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| DSP Small Cap Reg Gr | 0.94% | 20,221 | |
| Edelweiss Small Cap Reg Gr | 1.18% | 6,825 | |
| SBI Healthcare Opportunities Reg Gr | 1.89% | 5,400 | |
| DSP Healthcare Fund Reg Gr | 1.94% | 3,639 | |
| Tata India Pharma & Healthcare Reg Gr | 1.91% | 1,541 | |
| ITI Flexi Cap Reg Gr | 1.13% | 1,467 | |
| Groww Multicap Reg Gr | 0.61% | 924 | |
| Baroda BNP P Hlth and Wellness RegGr | 2.05% | 519 | |
| Quant Healthcare Reg Gr | 9.66% | 397 |
ETFs holding CONCORDBIO (0)
No tracked ETF holds CONCORDBIO ≥0.5%.